GPT and Hepatic fibrosis: In the validation cohort (n=132), 25 patients (18.94%) had normal ALT level and 86 patients (65.15%) had mildly increasing ALT level, of which 6 (24.00%) and 59 (68.60%) patients had significant necroinflammation, and 7 (28.00%) and 35 (40.70%) patients had significantly liver fibrosis, respectively.